Furthermore, caspase-10 mutations identified in PBC may simultaneously activate necroptosis and pyroptosis in macrophages, whereas therapies with ursodeoxycholic acid or obeticholic acid can partially reverse these aberrant death pathways [15]. This evidence concerns the gene CASP10 and primary biliary cholangitis.